logo

Viking Therapeutics, Inc. (VKTX)



Trade VKTX now with
  Date
  Headline
6/24/2021 7:12:59 AM Viking Therapeutics Begins Phase 1b Clinical Trial Of VK0214
6/24/2021 7:10:00 AM Viking Therapeutics Initiates Phase 1b Clinical Trial Of VK0214 In Patients With X-ALD
6/17/2021 7:08:40 AM Viking Therapeutics Announces Results From Phase 1 Clinical Trial Of Novel Oral Thyroid Receptor Beta Agonist VK0214
9/9/2020 7:09:54 AM Viking Therapeutics Says Commences Phase 1 Trial Of VK0214 As Potential Treatment For X-linked Adrenoleukodystrophy
8/28/2020 6:09:17 AM Viking Therapeutics Presents New Data From Phase 2 Study Of VK2809 In Patients With NAFLD And Elevated LDL-Cholesterol
8/20/2020 7:39:54 AM Viking To Present Data From Phase2 Study Of VK2809 In Patients With Non-Alcoholic Fatty Liver Disease&Elevated LDL-C
3/29/2019 7:45:58 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform
3/14/2019 8:44:35 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform
10/1/2018 7:51:04 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Market Perform
8/10/2018 7:55:42 AM William Blair Is Raising Viking Therapeutics, Inc. (VKTX) FY20 Estimate To -0.79 From -0.89
8/10/2018 7:55:29 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY19 Estimate To -0.55 From -0.69
8/10/2018 7:55:17 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY18 Estimate To -0.44 From -0.51
8/10/2018 7:54:42 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform